c2c12 cells (ATCC)
Structured Review

C2c12 Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 9248 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/c2c12 cells/product/ATCC
Average 99 stars, based on 9248 article reviews
Images
1) Product Images from "Attenuated lamin A–prohibitin2 interaction leads to mitochondrial dysfunction in LMNA 289 A>G–mediated dilated cardiomyopathy"
Article Title: Attenuated lamin A–prohibitin2 interaction leads to mitochondrial dysfunction in LMNA 289 A>G–mediated dilated cardiomyopathy
Journal: The Journal of Biological Chemistry
doi: 10.1016/j.jbc.2026.111274
Figure Legend Snippet: Loss of interaction with PHB2 complex in lamin A mutant K97E. A , schematic representation of the K97E mutation in the 1B domain of lamin A (not to scale). B , schematic overview of proximity-dependent biotinylation and streptavidin pulldown (BioID2) strategy. C , Z-projected immunofluorescence images showing localization of myc-BioID2-lamin A variants (the scale bar represents 2 μm). D , intensity profiles across the nuclear axis depicting myc-BioID2-lamin A and overall lamin A distribution. E , Pearson's correlation coefficient analysis showing colocalization between myc and lamin A signals. F , immunoblot of lamin A/C and GAPDH showing equal BioID2 input loading and comparable expression of BioID2-lamin A variants in HEK293T cells. G , number of interacting partners of WT and K97E lamin A as observed from protein identification through BioID2-pulldown followed by MS. H , Venn diagram indicating independent and overlapping interactome of WT and K97E lamin A. I , enrichment analysis of protein–protein interactions lost in the K97E mutant compared with WT lamin A. J , BioID2-based immunoblot analysis showing reduced interaction between lamin A and PHB2 in the K97E mutant compared with WT. K , quantitative PCR (qPCR) analysis of PHB1 and PHB2 mRNA levels, revealing differential expression in response to the K97E mutation in C2C12 cells. L , immunoblot analysis of PHB1, PHB2, GAPDH, and lamin A in C2C12 cells. M , densitometric quantification of PHB1 and PHB2 immunoblots, normalized to GAPDH. N , Z-projected immunofluorescence images of PHB2 showing altered subcellular distribution upon K97E lamin A expression (the scale bar represents 4 μm). O , quantitative analysis of PHB2 fluorescence intensity from immunofluorescence imaging. P , subcellular fractionation of cells expressing WT and K97E lamin A variants, followed by immunoblot against GAPDH (cytosolic marker), lamin A (nuclear marker), and PHB2. Q , densitometric quantification of PHB2 levels in the cytoplasmic fraction, normalized to GAPDH. R , in silico molecular docking of PHB2 with lamin A variants highlighting lamin A LYS97 and PHB2 GLU231 as potential perturbed interaction. S , blot overlay of purified lamin A proteins overlayed with whole cell lysate and probed with PHB2 to detect interaction. T , far Western of purified lamin A proteins with cell lysate and probed with PHB2 to detect interaction. HEK293T, human embryonic kidney 293T cell line; PHB2, prohibitin 2.
Techniques Used: Mutagenesis, Immunofluorescence, Western Blot, Expressing, Protein-Protein interactions, Real-time Polymerase Chain Reaction, Quantitative Proteomics, Fluorescence, Imaging, Fractionation, Marker, In Silico, Purification

